Brief: Kobayashi Pharmaceutical to acquire China-based pharmaceutical firm and set up control company in Shanghai
March 29 (Reuters) - Kobayashi Pharmaceutical Co Ltd
4967.T
* Says it will acquire 100 percent stake in Jiangsu-based
pharmaceutical firm from JIANGSU ZHONGDAN GROUP CO LTD, with
undisclosed price, effective June 30
* Says it will set up a control company in Shanghai, in
April, to
management business in China
Source text in Japanese:https://goo.gl/y1iCgh
Further company coverage: 4967.T
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +8601082555111;
Reuters Messaging: Pingping.Li1@thomsonreuters.com@reuters.net))
Recent news on Kobayashi Pharmaceutical
See all newsNotice Regarding Certain Media Reports
Brief: Japan's Kobayashi Pharmaceutical Considering Going Private Under Japan-UK Investment Fund Consortium, Bloomberg News Says
Brief: Oasis Management Raises Stake In Kobayashi Pharmaceutical To 14.41% From 13.37%, Filing Shows
Table: Kobayashi Pharmaceutical - 6-MTH group results
Brief: Oasis Management Company Is Making Shareholder Proposal To Kobayashi Pharmaceutical Co, Filing Shows